Ken Fisher’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.34M Buy
18,593
+4
+0% +$1.15K ﹤0.01% 471
2025
Q1
$5.73M Buy
18,589
+2,250
+14% +$694K ﹤0.01% 475
2024
Q4
$5.77M Buy
16,339
+10,034
+159% +$3.54M ﹤0.01% 486
2024
Q3
$2.26M Buy
6,305
+1,150
+22% +$412K ﹤0.01% 567
2024
Q2
$1.64M Buy
5,155
+334
+7% +$106K ﹤0.01% 616
2024
Q1
$1.11M Buy
4,821
+993
+26% +$228K ﹤0.01% 674
2023
Q4
$842K Buy
3,828
+209
+6% +$46K ﹤0.01% 713
2023
Q3
$817K Sell
3,619
-730
-17% -$165K ﹤0.01% 780
2023
Q2
$960K Buy
4,349
+23
+0.5% +$5.08K ﹤0.01% 783
2023
Q1
$969K Sell
4,326
-93
-2% -$20.8K ﹤0.01% 779
2022
Q4
$1.23M Buy
+4,419
New +$1.23M ﹤0.01% 735
2018
Q1
Sell
-2,649
Closed -$392K 822
2017
Q4
$392K Hold
2,649
﹤0.01% 682
2017
Q3
$310K Sell
2,649
-520
-16% -$60.9K ﹤0.01% 679
2017
Q2
$411K Buy
3,169
+45
+1% +$5.84K ﹤0.01% 620
2017
Q1
$423K Hold
3,124
﹤0.01% 579
2016
Q4
$448K Hold
3,124
﹤0.01% 572
2016
Q3
$369K Buy
3,124
+32
+1% +$3.78K ﹤0.01% 606
2016
Q2
$341K Hold
3,092
﹤0.01% 605
2016
Q1
$357K Sell
3,092
-45
-1% -$5.2K ﹤0.01% 595
2015
Q4
$491K Buy
3,137
+219
+8% +$34.3K ﹤0.01% 571
2015
Q3
$383K Buy
2,918
+468
+19% +$61.4K ﹤0.01% 574
2015
Q2
$426K Hold
2,450
﹤0.01% 468
2015
Q1
$422K Buy
+2,450
New +$422K ﹤0.01% 461